Investors Research Corp acquired a new position in Everus (NYSE:ECG – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,575 shares of the company’s stock, valued at approximately $169,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. SRS Capital Advisors Inc. bought a new position in Everus in the 4th quarter worth approximately $26,000. Principal Securities Inc. bought a new position in Everus in the 4th quarter worth approximately $27,000. HighMark Wealth Management LLC bought a new position in Everus in the 4th quarter worth approximately $28,000. Crews Bank & Trust bought a new position in Everus in the 4th quarter worth approximately $29,000. Finally, Mendota Financial Group LLC bought a new position in Everus in the 4th quarter worth approximately $36,000.
Everus Stock Down 4.0 %
Shares of NYSE ECG opened at $38.36 on Tuesday. The firm’s fifty day moving average price is $60.08. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. Everus has a 1 year low of $37.18 and a 1 year high of $77.93.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on ECG. Wolfe Research began coverage on Everus in a report on Tuesday, December 3rd. They issued a “peer perform” rating for the company. Stifel Nicolaus decreased their price target on Everus from $85.00 to $67.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Oppenheimer increased their price target on Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Tuesday, January 7th.
Check Out Our Latest Report on Everus
Insider Buying and Selling
In related news, Director Edward A. Ryan purchased 1,400 shares of the firm’s stock in a transaction that occurred on Tuesday, February 25th. The stock was acquired at an average price of $38.02 per share, for a total transaction of $53,228.00. Following the transaction, the director now directly owns 14,928 shares of the company’s stock, valued at $567,562.56. This trade represents a 10.35 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Rocca Michael Della purchased 1,050 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was bought at an average cost of $47.56 per share, for a total transaction of $49,938.00. Following the purchase, the director now directly owns 2,027 shares in the company, valued at $96,404.12. This represents a 107.47 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 3,750 shares of company stock worth $153,853 in the last three months.
Everus Company Profile
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Featured Articles
- Five stocks we like better than Everus
- How to Calculate Retirement Income: MarketBeat’s Calculator
- How to Protect Your Portfolio When Inflation Is Rising
- Consumer Staples Stocks, Explained
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What is the Nasdaq? Complete Overview with History
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECG – Free Report).
Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.